Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (3718)	1/5/2006 9:08:58 PM
From: manny_velasco	Read Replies (1) \| Respond to of 12215

Yep you got the right stock. The first failed phase 3 the radiation sensitizer worked real good on brain cancer and sucked big time on liver cancer. FDA vote was one shy of passing. They went back and done the brain cancer again and the results are due real soon. Warburg owns somewhere around 40% of the stock. I can not remember how many other drugs they have in the pipeline. Also check the news to see who the new board member is (think he was a big wig at ELN btw all of this info is off the top of my head)